MQ and the Academy of Medical Sciences have rapidly convened an expert group to develop mental health and neuroscience research priorities to COVID-19.
The mental health implications of COVID-19 are already significant, and will grow with the scale and length of the outbreak. At MQ we believe strongly that the UK and global research response to COVID-19 must include mental health.
There is growing recognition that the mental health impacts of the coronavirus (COVID-19) pandemic will be significant for us all – for those with existing mental health conditions and for everyone affected by stress, anxiety, isolation, loneliness, family pressure and financial hardship.
MQ is committed to supporting our grantholders and those applying for grants during this uncertain period. This page provides an update on key operational issues around our research funding.
In new research, MQ Fellow Dr Ethel Nakimuli-Mpungu has successfully trialled an innovative way to increase access to effective mental health care in Sub-Saharan Africa.
Dr Petra Vértes is one of our 2017 Fellows. She’s at the University of Cambridge exploring what’s going on in the brain when symptoms of schizophrenia arise, with the hope of supporting the development of new targeted treatments.
A report published today shows that in 2018 mental health research received 6.1% of the overall UK health research budget - an increase of 0.51% since 2014.
An MQ funded study published today has successfully developed a predictive tool that could help recognise young people who are at high or low risk of depression in young adulthood.